Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis

被引:38
|
作者
Guidozzi, Nadia [1 ]
Wiggins, Tom [1 ]
Ahmed, Ahmed R. [1 ]
Hanna, George B. [1 ]
Markar, Sheraz R. [1 ]
机构
[1] Imperial Coll London, Dept Surg & Canc, London, England
关键词
fundoplication; gastroesophageal reflux disease; magnetic sphincter augmentation; NISSEN FUNDOPLICATION; MANAGEMENT-SYSTEM; OUTCOMES; COMPLICATIONS; MULTICENTER; TRIAL;
D O I
10.1093/dote/doz031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Magnetic sphincter augmentation (MSA) has been proposed as a less invasive, more appealing alternative intervention to fundoplication for the treatment of gastroesophageal reflux disease (GERD). The aim of this study was to evaluate clinical outcomes following MSA for GERD control in comparison with laparoscopic fundoplication. A systematic electronic search for articles was performed in Medline, Embase, Web of Science, and Cochrane Library for single-arm cohort studies or comparative studies (with fundoplication) evaluating the use of MSA. A random-effects meta-analysis for postoperative proton pump inhibitor (PPI) use, GERD-health-related quality of life (GERD-HRQOL), gas bloating, ability to belch, dysphagia, and reoperation was performed. The systematic review identified 6 comparative studies of MSA versus fundoplication and 13 single-cohort studies. Following MSA, only 13.2% required postoperative PPI therapy, 7.8% dilatation, 3.3% device removal or reoperation, and esophageal erosion was seen in 0.3%. There was no significant difference between the groups in requirement for postoperative PPI therapy (pooled odds ratio, POR = 1.08; 95%CI 0.40-2.95), GERD-HRQOL score (weighted mean difference, WMD= 0.34; 95%CI -0.70-1.37), dysphagia (POR = 0.94; 95%CI 0.57-1.55), and reoperation (POR = 1.23; 95%CI 0.26-5.8). However, when compared to fundoplicationMSA was associated with significantly less gas bloating (POR = 0.34; 95%CI 0.16-0.71) and a greater ability to belch (POR = 12.34; 95%CI 6.43-23.7). In conclusion, magnetic sphincter augmentation achieves good GERD symptomatic control similar to that of fundoplication, with the benefit of less gas bloating. The safety of MSA also appears acceptable with only 3.3% of patients requiring device removal. There is an urgent need for randomized data directly comparing fundoplication with MSA for the treatment of GERD to truly evaluate the efficacy of this treatment approach.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease
    Schwameis, Katrin
    Nikolic, Milena
    Castellano, Deivis G. Morales
    Steindl, Ariane
    Macheck, Sarah
    Kristo, Ivan
    Zoerner, Barbara
    Schoppmann, Sebastian F.
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3263 - 3269
  • [22] Laparoscopic fundoplication for gastroesophageal reflux disease in infants and children
    Iwanaka, Tadashi
    Kanamori, Yutaka
    Sugiyama, Masahiko
    Komura, Makoto
    Tanaka, Yujiro
    Kodaka, Tetsuro
    Ishimaru, Tetsuya
    SURGERY TODAY, 2010, 40 (05) : 393 - 397
  • [23] Magnetic sphincter augmentation in the management of gastro-esophageal reflux disease: a systematic review and meta-analysis
    Fadel, Michael G.
    Tarazi, Munir
    Dave, Madhav
    Reddy, Marcus
    Khan, Omar
    Fakih-Gomez, Naim
    Ashrafian, Hutan
    Fehervari, Matyas
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (10) : 6355 - 6366
  • [24] Clinical efficacy and safety of magnetic sphincter augmentation (MSA) and transoral incisionless fundoplication (TIF2) in refractory gastroesophageal reflux disease (GERD): a systematic review and meta-analysis
    Chandan, Saurabh
    Mohan, Babu P.
    Khan, Shahab R.
    Jha, Lokesh K.
    Dhaliwal, Amaninder J.
    Bilal, Mohammad
    Aziz, Muhammad
    Canakis, Andrew
    Arora, Sumant
    Malik, Sarah
    Kassab, Lena L.
    Ponnada, Suresh
    Bhat, Ishfaq
    Hewlett, Alexander T.
    Sharma, Neil
    McDonough, Stephanie
    Adler, Douglas G.
    ENDOSCOPY INTERNATIONAL OPEN, 2021, 09 (04) : E583 - E598
  • [25] LINX™ Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease
    Bonavina, Luigi
    DeMeester, Tom R.
    Ganz, Robert A.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 667 - 674
  • [26] Laparoscopic alternatives to fundoplication for gastroesophageal reflux: the role of magnetic augmentation and electrical stimulation of the lower esophageal sphincter
    Bonavina, L.
    Attwood, S.
    DISEASES OF THE ESOPHAGUS, 2016, 29 (08): : 996 - 1001
  • [27] Magnetic Sphincter Augmentation Outcomes in Severe Gastroesophageal Reflux Disease
    Ferrari, Davide
    Siboni, Stefano
    Riva, Carlo Galdino
    Guerrazzi, Guglielmo
    Lovece, Andrea
    Bonavina, Luigi
    FRONTIERS IN MEDICINE, 2021, 8
  • [28] Magnetic Sphincter Augmentation for the Treatment of Gastroesophageal Reflux Disease
    Patti, Marco G.
    Herbella, Fernando A. M.
    WORLD JOURNAL OF SURGERY, 2022, 46 (09) : 2251 - 2252
  • [29] Laparoscopic Posterior Partial Fundoplication for Gastroesophageal Reflux Disease
    Sanchez-Casalongue, Manuel E.
    Farrell, Timothy M.
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2020, 30 (06): : 642 - 648
  • [30] Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD
    Reynolds, Jessica L.
    Zehetner, Joerg
    Nieh, Angela
    Bildzukewicz, Nikolai
    Sandhu, Kulmeet
    Katkhouda, Namir
    Lipham, John C.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (08): : 3225 - 3230